Inventor · disambiguated record
Yimin Jiang
Also filed as: JIANG YIMIN
14 granted patents·17 pending applications·39 citations·filing 2003–2023
89Inventor score
Files withEISAI R&D MAN CO LTD9JANSSEN SCIENCES IRELAND UNLIMITED CO7SIRONAX LTD4JANSSEN PHARMACEUTICA NV3BOIVIN ROCH2
Top patents by PatentIndex Score
31 records- 0185US8937056B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2013·Granted Jan 20, 2015·3 cites·14 claims
- 0284US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 0382US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 0476US7314936B2Deazapurines and uses thereofEISAI CO LTD·Filed 2003·Granted Jan 1, 2008·8 cites·34 claims
- 0569US11160783B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·18 claims
- 0667US11434246B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2021·Granted Sep 6, 2022·0 cites·30 claims
- 0767US8609640B2Multikinase inhibitors for use in the treatment of cancerAGOULNIK SERGEI·Filed 2008·Granted Dec 17, 2013·1 cites·15 claims
- 0866US10941148B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 9, 2021·0 cites·22 claims
- 0963US8691814B2Deazapurines and uses thereofDAUN JANE·Filed 2010·Granted Apr 8, 2014·1 cites·35 claims
- 1061US7868002B2Deazapurines and uses thereofEISAI R&D MAN CO LTD·Filed 2007·Granted Jan 11, 2011·0 cites·31 claims
- 1160US7524883B2Eponemycin and epoxomicin analogs and uses thereofEISAI R&D MAN CO LTD·Filed 2003·Granted Apr 28, 2009·1 cites·52 claims
- 1259US10316040B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2016·Granted Jun 11, 2019·0 cites·20 claims
- 1359US2015182496A1Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2015·Application pending·0 cites
- 1459US2025326726A1Ferroptosis inhibitors-phenoxazine acetamidesSIRONAX BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 1556US2009291998A1Eponemycin and epoxomicin analogs and uses thereofEISAI R&D MAN CO LTD·Filed 2009·Application pending·0 cites
- 1654US2025179061A1Rip1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 1753US11053235B2Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Jul 6, 2021·0 cites·17 claims
- 1852US2022348571A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Application pending·0 cites
- 1951US2021220356A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Application pending·0 cites
- 2051US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 2150US2023002408A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2249US2024327393A1Ferroptosis modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 2349US2025236613A1Sarm1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 2448US11639350B2Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infectionsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 2, 2023·0 cites·23 claims
- 2548US2022267313A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 2647US2022348592A1Fused heterocyclic derivativesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 2747US2024360114A1Ferroptosis modulators, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 2846US2023165865A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2946US2022281865A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
- 3044US2022048919A1Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis b infectionsJanssen Phrmaceutica NV·Filed 2019·Application pending·0 cites
- 3140US2023083012A1Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseasesJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yimin Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →